New vectored vaccines for malaria.
Hill Avs., Sarah C. Gilbert(Nuffield Orthopaedic Centre), Loredana Siani(Nouscom (Italy)), Eleanor Berrie(University of Oxford), Saroj Saurya(Centre for Human Genetics), Alfredo Nicosia(Ospedale Antonio Cardarelli), Migena Bregu(University of Oxford), Stefano Colloca(RINA Consulting - Centro Sviluppo Materiali S.p.A. (Italy)), Geraldine O’Hara(University of London), Julie Furze(University of Oxford), Christine S. Rollier(University of Oxford), Alison M. Lawrie(University of Oxford), Simon J. Draper(University of Oxford), Anthony Calvert, Alexandra J. Spencer(University of Oxford), Hildegund C.J. Ertl(The Wistar Institute), Sumi Biswas(University of Oxford), Saranya Sridhar(Sanofi (France)), Alan G. Goodman(Washington State University), Matthew G. Cottingham(University of Oxford), Anne Moore(University College Cork), Arturo Reyes‐Sandoval(Instituto Politécnico Nacional), Rosalind Rowland, David Wyllie(John Radcliffe Hospital), K Larsen, Rosaria Cortese, P Bird, Emily K. Forbes(University of Oxford)
International Journal for Parasitology
January 1, 2008
Cited by 0
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
|New England Journal of Medicine|2018|779